Prospective phase II study of prophylactic low-dose azacitidine and donor lymphocyte infusions following allogeneic hematopoietic stem cell transplantation for high-risk acute myeloid leukemia and myelodysplastic syndrome - Université de Lorraine Accéder directement au contenu
Article Dans Une Revue Bone Marrow Transplantation Année : 2019

Prospective phase II study of prophylactic low-dose azacitidine and donor lymphocyte infusions following allogeneic hematopoietic stem cell transplantation for high-risk acute myeloid leukemia and myelodysplastic syndrome

Reza Tabrizi
  • Fonction : Auteur
Stéphane Vigouroux
  • Fonction : Auteur
Marie-Thérèse Rubio
Noël Milpied
  • Fonction : Auteur

Dates et versions

hal-02977226 , version 1 (24-10-2020)

Identifiants

Citer

Thierry Guillaume, Florent Malard, Leonardo Magro, Myriam Labopin, Reza Tabrizi, et al.. Prospective phase II study of prophylactic low-dose azacitidine and donor lymphocyte infusions following allogeneic hematopoietic stem cell transplantation for high-risk acute myeloid leukemia and myelodysplastic syndrome. Bone Marrow Transplantation, 2019, 54 (11), pp.1815-1826. ⟨10.1038/s41409-019-0536-y⟩. ⟨hal-02977226⟩
39 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More